CARsgen Therapeutics
Developing CAR T-cell therapies
- B2B
- B2C
About CARsgen Therapeutics
A biopharmaceutical company focusing on innovative CAR T-cell therapies for hematologic malignancies and solid tumors, with integrated capabilities from target discovery to commercial manufacturing
Key facts
- Industry
- Biotechnology
- Company size
- 51–250 employees
- Headquarters
- Shanghai, China
- Founded
- 2014
- Revenue
- CNY 126MFY2025, publicly reported
- Website
- carsgen.com
CARsgen Therapeutics at a glance
CARsgen Therapeutics is a B2B/B2C company in the Biotechnology industry, headquartered in Shanghai, China.
CARsgen Therapeutics was founded in 2014.
CARsgen Therapeutics has 51–250 employees.
CARsgen Therapeutics's revenue is CNY 126M (FY2025, publicly reported).
Frequently asked questions about CARsgen Therapeutics
What is CARsgen Therapeutics's revenue?
CARsgen Therapeutics's revenue is CNY 126M (FY2025, publicly reported).
How many employees does CARsgen Therapeutics have?
CARsgen Therapeutics has 51–250 employees.
Where is CARsgen Therapeutics headquartered?
CARsgen Therapeutics is headquartered in Shanghai, China.
Selling to companies like CARsgen Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies